Most Recent Articles by Jody A. Charnow, Editor
Fresenius Medical Care North America has promoted Ahmad Sharif, MD, MPH, to Chief Medical Information Officer for North America.
Apalutamide prolonged metastasis-free survival by 2 years compared with placebo.
Added to hormone therapy, docetaxel offers a cost effective way to prolong hormone-sensitive disease and improve quality of life years, especially among men with non-metastatic disease, study finds.
End-stage renal disease is more likely to develop in individuals with serum albumin levels of 4.1 g/dL or below than in those with levels of 4.4 g/dL or higher.
Patients with bladder adenocarcinomas have the best survival, whereas those with small cell carcinomas of the bladder have the worst.
More Articles by Jody A. Charnow, Editor
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)